04 March AMR Workshop optimising veterinary antimicrobial use and reducing antimicrobial resistance (AMR): from policy to practice
Activities data
- -
- Online
In 2017, the EU launched an Action against antimicrobial resistance (AMR) under the name “one health”. Every year around 33,000 people in the EU die from AMR. The total costs of AMR, for example for health care, have been estimated at approximately 1.5 billion Euros per year. That is why the reduction of antimicrobial resistance is one of the spearheads of the new Regulation on veterinary medicines (2019/6).
For example, prescription of antibiotics will only be allowed in very exceptional situations after January 28, 2022 when the regulation comes into force. In addition, Member States will have to enter the use and sale of antibiotics (and other antimicrobial substances) in an EMA database.
Because of all these changes, an AMR workshop was organized by the International Collaboration Program (ICP, residing under the Dutch Medicines Evaluation Board), SDa (Dutch Veterinary Medicines Institute) and the European Medicines Agency EMA (their training department EU-NTC).
This workshop was held on March 4 and 5, 2021. The latest scientific facts about AMR and antibiotic use were highlighted in several lectures. Research results of AMR in both humans and animals were presented in detail. One presentation discussed on the interpretation of antimicrobial use and sales data in the context of entering these data into the EMA database. In addition, the possibilities on reduction of use of antimicrobial agents on farms were investigated.
Programme
4 March
Introduction
Dr. H.M.G. Schreurs (Netherlands Veterinary Medicine Institute)
Monitoring and benchmarking antimicrobial use in the Netherlands
Prof. dr. ir. D.J.J. Heederik (IRAS, UU, Utrecht)
Antimicrobial usage in animals in Belgium and Europe
Prof. dr. J. Dewulf (UGent, Gent, Belgium)
AMR-monitoring in animals in the Netherlands (including MRSA/ESBLs)
Dr. K.T. Veldman (WVBR-WUR, Lelystad)
5 March
The global AMR situation
Prof. dr. M.J.M. Bonten (UMC Utrecht)
AMR in animals and its public health impact
Prof. dr. D.M. Mevius
Regulation EU 2019/6 and impact on prescription of AM’s in veterinary practices in the NL
Dr. I.M. van Geijlswijk (Pharmacie, UU, Utrecht)
Optimising veterinary antimicrobial use and reducing AMR: from policy to practice, results from 2 intervention studies
Drs. M. Houben (Royal GD Deventer)